Publication|Articles|September 9, 2024
Supplements and Featured Publications
- Prioritizing LDL-Cholesterol Control
Prioritizing LDL-Cholesterol Control
Listen
0:00 / 0:00
Key Takeaways
- LDL cholesterol management is vital for reducing cardiovascular disease risk and improving patient outcomes through effective lipid-lowering therapies.
- Advancements in therapies, such as PCSK9 inhibitors and statins, have significantly reduced LDL levels, enhancing cardiovascular health.
Advertisement
This supplement highlights the critical role of LDL cholesterol management in reducing cardiovascular disease and improving outcomes.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
CAR T-Cell Therapies, Bispecific Antibodies Usher in New Era in R/R MCL
2
Global CKD Burden Nearly Doubles Since 1990, Reaching 788 Million Adults Worldwide
3
Trial Data Yield Risk-Based NRSTS Treatment Strategies
4
FDA Approves Pembrolizumab Plus Enfortumab Vedotin for MIBC
5










































